News Related to Lesion Size

Related coverage linked through entity extraction aliases.

AI workflow predicts colorectal cancer risk in ulcerative colitis with 99% accuracy

Apr 04, 2026

A study published on February 17, 2026 validated an AI workflow that predicted colorectal cancer risk in ulcerative colitis with 99% accuracy using over 55,000 patient records. The model identified low-risk and higher-risk patients from clinical notes, colonoscopy reports, and pathology findings.

Ocular Therapeutix's Axpaxli Outperforms Eylea in Wet AMD Trial

Mar 24, 2026

Ocular Therapeutix's experimental drug Axpaxli showed superior vision maintenance compared to Regeneron's Eylea in a late-stage wet AMD trial. Meanwhile, Ocugen reported 12-month data showing its gene therapy OCU410 reduced geographic atrophy lesions by 31%, though less than earlier interim results. Both companies are advancing toward regulatory submissions and further clinical development.